We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Trump’s Policy on Prescription Drug Rebates Pushed Back Until 2023
Trump’s Policy on Prescription Drug Rebates Pushed Back Until 2023
The Biden administration has moved to delay until January 2023 the implementation of a key Trump-era policy that would effectively bar pharma companies and pharmacy benefit managers (PBMs) from negotiating prescription drug rebates.